Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

This study has been terminated.
(Terminated due to slow accrual.)
Sponsor:
Collaborators:
The EMMES Corporation
Information provided by (Responsible Party):
AIDS Malignancy Consortium
ClinicalTrials.gov Identifier:
NCT00427414
First received: January 25, 2007
Last updated: April 28, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)